1st Quarter - Report

VIATRIS INC. for VIATRIS INC

Period 1st Quarter 2012 Filed Apr 20, 2012 Signed by Lara Ramsburg, VP Government Relations

Official filing
Firm
VIATRIS INC.
Client
VIATRIS INC
Income
—
Expenses
$356,337
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent settlements

LobbyistCovered position, as disclosed
ELLEN JENKINS New —
LARA RAMSBURG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

User Fees; Drug Shortages; Patent Settlements; Food, Drug, and Cosmetic Act (FDCA); Globalizing the FDA; Serialization; Access to epinephrine auto-injectors in an emergency; Issues relating to HIV/AIDS, funding for Antiretrovirals (ARVs), PEPFAR, Global Fund; Issues relating to biosimilars; Issues relating to the generic drug industry; Issues relating to Average Manufacturer Price (AMP)

LobbyistCovered position, as disclosed
ELLEN JENKINS New —
BRUCE LOTT —
MARCIE MCCLINTIC-COATES New —
LARA RAMSBURG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.